Aditi Technologies, a leading provider of software product and application development services, has developed an Intellectual Property led solution with ‘DNA PReDuST’. The solution is deployed on Microsoft Biology Foundation (MBF). This is a bioinformatics platform offering, co-engineered by Aditi & Microsoft.
DNA PReDuST or “DNA Parallel Restriction Digestion using Suffix Trees”, is an in-silico software solution targeted at scientists involved in bioinformatics, genomics and pharma research to identify appropriate slots in a DNA sequence at which it can be cleaved for in-vitro experiments.
What makes it stand out is the fact that this is the first solution in the market that not only supports all kinds of restriction enzymes (Type I, II and III) but also takes into account real time laboratory conditions like temperature and pH values while conducting the experiments. The solution helps to enhance the test accuracy, reducing multiple iterations and cycle time. In the long run, it provides the much-needed economies of scale to users.
It also offers intuitive visualizations for DNA’s restriction and digestion maps, which are significant productivity accelerators for researchers.
MBF is an NET platform based open-source platform of reusable bioinformatics algorithms, services and functions which makes it easy to distribute computations and workflows and visualize massive data sets.
According to Pankaj Jindal, president – Aditi Technologies, IP-based solutions are exciting and firmly in-line with our vertical alignment strategy. This solution is a testimony of Aditi’s bioinformatics software engineering prowess and deep understanding of industry pain points.
Welcoming the move, Simon Mercer, director of Health and Wellbeing – Microsoft, said, “We at Microsoft are happy to see Aditi Technologies taking a lead in extending Microsoft Biology Foundation. This is a step towards unleashing the true potential of this framework and we offer our support and best wishes for the success of this effort.”
Aditi Technologies is a core member of Microsoft led BioIT Alliance which is a cross-industry group working to integrate science and technology to accelerate bioinformatics and pharmaceutical research.
The 16-year-old Bangalore-based Aditi Technologies has strengthened its capability with innovative IP solutions. Its offices are at Seattle, Boston, London, Mountain View, and New York City.